To investigate whether DNAm changes may mediate the relationship between CHIP and CAD4,5, we tested whether DNAm at CHIP-associated CpGs causally influences the risk for CAD using two-sample Mendelian randomization (MR). This evidence concerns the gene CDH4 and coronary artery disorder.